Delek US (NYSE:DK – Get Free Report) will be posting its quarterly earnings results before the market opens on Tuesday, August 6th. Analysts expect Delek US to post earnings of $0.77 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
Delek US (NYSE:DK – Get Free Report) last released its quarterly earnings data on Tuesday, May 7th. The oil and gas company reported ($0.41) earnings per share for the quarter, beating the consensus estimate of ($0.56) by $0.15. Delek US had a positive return on equity of 7.37% and a negative net margin of 0.48%. The business had revenue of $3.23 billion for the quarter, compared to analysts’ expectations of $3.28 billion. During the same quarter in the previous year, the business posted $1.37 EPS. Delek US’s revenue for the quarter was down 17.8% on a year-over-year basis. On average, analysts expect Delek US to post $-3 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Delek US Stock Performance
Shares of DK opened at $21.82 on Monday. The firm has a market cap of $1.40 billion, a P/E ratio of -17.60 and a beta of 1.19. Delek US has a twelve month low of $21.15 and a twelve month high of $33.60. The company has a debt-to-equity ratio of 2.40, a quick ratio of 0.64 and a current ratio of 1.04. The firm’s 50 day moving average price is $23.95 and its two-hundred day moving average price is $26.75.
Delek US Increases Dividend
Analysts Set New Price Targets
Several analysts have issued reports on DK shares. TD Cowen downgraded Delek US from a “hold” rating to a “sell” rating and dropped their price target for the company from $25.00 to $20.00 in a research note on Monday, June 10th. Mizuho dropped their target price on Delek US from $31.00 to $27.00 and set an “underperform” rating on the stock in a research report on Thursday, June 20th. Wolfe Research began coverage on Delek US in a research report on Thursday, July 18th. They set an “underperform” rating and a $19.00 price target for the company. Wells Fargo & Company lowered their price objective on shares of Delek US from $25.00 to $20.00 and set an “underweight” rating on the stock in a report on Tuesday, July 16th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Delek US from $25.00 to $23.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 2nd. Five equities research analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, Delek US presently has a consensus rating of “Hold” and a consensus price target of $25.50.
Read Our Latest Analysis on Delek US
Insider Buying and Selling at Delek US
In other Delek US news, Director Richard J. Marcogliese purchased 2,750 shares of Delek US stock in a transaction that occurred on Wednesday, June 12th. The stock was acquired at an average price of $23.99 per share, for a total transaction of $65,972.50. Following the completion of the acquisition, the director now owns 42,863 shares of the company’s stock, valued at approximately $1,028,283.37. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders sold a total of 2,854 shares of company stock worth $71,078 over the last quarter. 1.80% of the stock is currently owned by insiders.
Delek US Company Profile
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
See Also
- Five stocks we like better than Delek US
- Best Stocks Under $5.00
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Insider Buying Explained: What Investors Need to Know
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Delek US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delek US and related companies with MarketBeat.com's FREE daily email newsletter.